Designing lenalidomide cocrystals with an extended-release profile for improved pulmonary drug delivery
New Journal of Chemistry · 2025 · 49 (16) · 6535-6543
DOI: 10.1039/d5nj00425j ↗Kurz gefasst
Fachartikel in der Zeitschrift New Journal of Chemistry, 2025. Verfasst von Martin A. Screen und 6 weiteren Autor:innen. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Engineering and Physical Sciences Research Council, AstraZeneca.
Abstract (Originalsprache)
This work describes a lenalidomide–melamine cocrystal with a lower solubility than pure lenalidomide, making it suitable for inhalable formulations.
Förderung
- Engineering and Physical Sciences Research Council
- AstraZeneca
Zitieren
APA
Screen, M. A., Tomkinson, G., McCabe, J. F., Askin, S., Mahon, C. S., Wilson, M. R., & Steed, J. W. (2025). Designing lenalidomide cocrystals with an extended-release profile for improved pulmonary drug delivery. New Journal of Chemistry, 49(16), 6535-6543. https://doi.org/10.1039/d5nj00425j
Vancouver
Screen MA, Tomkinson G, McCabe JF, Askin S, Mahon CS, Wilson MR, et al. Designing lenalidomide cocrystals with an extended-release profile for improved pulmonary drug delivery. New Journal of Chemistry. 2025;49(16):6535-6543. doi:10.1039/d5nj00425j
BibTeX
@article{Screen2025,
author = {Screen, Martin A. and Tomkinson, Gary and McCabe, James F. and Askin, Sean and Mahon, Clare S. and Wilson, Mark R. and Steed, Jonathan W.},
title = {Designing lenalidomide cocrystals with an extended-release profile for improved pulmonary drug delivery},
journal = {New Journal of Chemistry},
year = {2025},
volume = {49},
number = {16},
pages = {6535--6543},
doi = {10.1039/d5nj00425j}
}
EUVIMED